Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07YPB
|
|||
| Drug Name |
Hu-CART meso cells
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Fallopian tube cancer [ICD-11: 2C74; ICD-10: C57.0] | Phase 1 | [1] | |
| Lung cancer [ICD-11: 2C25.0; ICD-9: 162] | Phase 1 | [1] | ||
| Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 1 | [1] | ||
| Peritoneal mesothelioma [ICD-11: 2C51.2] | Phase 1 | [1] | ||
| Pleural mesothelioma [ICD-11: 2C26.0] | Phase 1 | [1] | ||
| Company |
University of Pennsylvania
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mesothelin (MSLN) | Target Info | CAR-T-Cell-Therapy | [1] |
| NetPath Pathway | TCR Signaling Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03054298) CAR T Cells in Mesothelin Expressing Cancers | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.